Windlas Biotech Ltd Share Price Today - Windlas Biotech Ltd Stock Price Live NSE/BSE

Windlas Biotech Ltd

NSE: WINDLAS BSE: 543329

₹822.80

(-3.72%)

Mon, 11 May 2026, 04:52 pm

MTF 5xInvest in Windlas Biotech Ltd with 5x Leverage Buy with MTF

Market Cap17.37B

PE Ratio26.14

Dividend0.71

Health Technology

Pharmaceuticals: Major

24.5K

Windlas Biotech Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1731.87
Net Profit
60.99
P/B
4.31
Sector P/E
34.27
P/E
35.78
EV/EBITDA
19.61
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.95
ROCE (Industry)
16.47
RONW (Industry)
14.44
ROE
12.76
ROCE
16.87
Debt/Equity
0.04
EPS (TTM)
31.62
Dividend Yield
0.70
Book Value
253.05
Interest Cover
19.21

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	61.90	61.99	61.99	62.34	62.34
FII	0.60	0.93	1.11	1.44	1.52
DII	11.81	11.44	11.43	11.21	10.89
Public	25.70	25.64	25.47	25.01	25.25
Government	0	0	0	0	0

Technical Analysis

RSI

40.81

MACD

10.44

50 DMA

793.13

200 DMA

859.32

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	1142.48	986.88	919.37	831.28	763.77	675.68	520.08
Fibonacci	986.88	927.44	890.72	831.28	771.84	735.12	675.68
Camarilla	894.64	880.38	866.11	831.28	837.59	823.32	809.06

Pivots Level: Classic

+311.20

1142.48

+155.60

986.88

+88.08

919.37

831.28

Pivot Point

LTP: 798.80

-67.52

763.77

-155.60

675.68

-311.20

520.08

Moving Average

SMAEMA

Period

Value

10-EMA
842.59
20-EMA
839.00
30-EMA
829.36
50-EMA
817.02
100-EMA
816.74
200-EMA
838.69

Announcement Date	Purpose	Action	Ex Date
17 Apr 2026	buyback
05 Feb 2026	board-meetings	Quarterly Results
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
04 Jul 2025	agm
21 Jun 2025	dividend	Final Dividend - Rs. - 5.8	21 Jul 2025
22 May 2025	dividend	₹5.80 Dividend /Share	21 Jul 2025
02 Sept 2024	agm
17 Aug 2024	dividend	Dividend - Rs 5.50 Per Share	17 Sept 2024
17 Aug 2024	agm	Annual General Meeting	18 Sept 2024
20 May 2024	dividend	₹5.50 Dividend /Share	17 Sept 2024

Windlas Biotech Ltd

Cipla Ltd

Lupin Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd

Windlas Biotech Ltd About

Windlas Biotech is engaged in manufacturing and trading of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

2001

Headquarters

CEO

Vivek Dhariwal

Employees

Contact

Website

http://www.windlasbiotech.com

grievance@windlasbiotech.com

Phone

91-135-6608000

Location

40/1 Mohabewala Industrial, Area, Dehradun, Uttarakhand, 248110

Year	History
2016	The Company was converted into a private limited company. A fresh certificate of incorporation consequent upon conversion and change of name to Windlas Biotech Private Limited was granted.
2017	Revenues crossed Rs. 3,000 million for the FY 2016-17.
2018	The Company launched its first product in the United States from Dehradun Plant – IV. The Company commenced operations at Dehradun Plant – III.
2021	The Company was converted from a private limited company to a public limited company. The name of the Company was changed to Windlas Biotech Limited. A fresh certificate of incorporation was granted by the RoC. Approval of Scheme of Amalgamation of the erstwhile subsidiary, Windlas Healthcare, with and into the Company was obtained.
2022	The Company received a certificate of Good Manufacturing Practices (GMP) from SAHPRA.

Client Name	Order Side	QTY	Avg Price	Date
AJAY KUMAR AGGARWAL	Buy	144995	787.42	20 Feb 2025
SAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAP	Sell	115374	683.49	19 Feb 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	110668	565.96	01 Mar 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	110668	564.94	01 Mar 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	135363	522.39	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	135363	522.27	08 Feb 2024
JAINAM BROKING LIMITED	Buy	150028	511.5	02 Jan 2024
JAINAM BROKING LIMITED	Sell	96128	520.7	02 Jan 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	409737	517.17	02 Jan 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	409737	517.5	02 Jan 2024

Windlas Biotech Ltd News

Windlas Biotech Appoints New Independent Woman Director

Windlas Biotech appoints Dr. Tarashree Singhal as Additional Independent Woman Director from May 5, 2026, while Mr. Srinivasan Venkataraman completes his five-year term and ceases as director.

05 May 2026

companies

Windlas Biotech Appoints New Independent Woman Director

Windlas Biotech appoints Dr. Tarashree Singhal as Additional Independent Woman Director from May 5, 2026, while Mr. Srinivasan Venkataraman completes his five-year term and ceases as director.

05 May 2026

companies

Windlas Biotech Announces Share Buyback Opening

Windlas Biotech Limited opens buyback offer for 4,70,000 equity shares at INR 1,000 per share, scheduled from April 30 to May 07, 2026, representing 2.23% of total equity capital.

30 Apr 2026

companies

Windlas Biotech Approves ₹47 Crore Share Buyback

Windlas Biotech's board approved buyback of 4,70,000 equity shares at ₹1,000 per share, totaling ₹47 crore. Record date fixed for April 24, 2026 to determine shareholder eligibility.

22 Apr 2026

companies

Windlas Biotech Approves ₹470 Cr Share Buyback Plan

Windlas Biotech board approved buyback of 4.70 lakh equity shares at ₹1,000 per share for ₹470 crore, representing 2.23% of paid-up capital. Record date fixed as April 24, 2026.

17 Apr 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800